Inhibition of hippocampal mossy fiber plasticity and episodic memory by human Aβ oligomers is prevented by enhancing cAMP signaling in Alzheimer's mice
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Shan-Xue Jin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Ann Romney Center for Neurologic Diseases, Department of Neurology, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, U…. Hauptthemen laut MEDLINE: Alzheimer Disease, Cyclic AMP, Mossy Fibers, Hippocampal, Amyloid beta-Peptides. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH Blueprint for Neuroscience Research, The Davis Alzheimer's Prevention Program.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Early episodic memory impairment in Alzheimer's disease (AD) is linked to synaptic dysfunction from amyloid β‐protein oligomers (oAβ), particularly affecting the dentate gyrus mossy fiber‐CA3 pathway. The APP NL‐G‐F mouse model exhibits early deficits in mossy fiber long‐term potentiation (mf‐LTP). METHODS We administered the β‐adrenergic receptor agonist isoproterenol (ISO) in vivo and phosphodiesterase type 4 inhibitor GSK356278 in vitro to assess their impact on mf‐LTP and contextual fear memory. Fluorescence lifetime imaging (FLIM)‐Förster resonance energy transfer (FRET) microscopy was used to visualize impaired and rescued cyclic adenosine monophosphate (cAMP) signaling in dentate gyrus neurons. RESULTS ISO prevented mf‐LTP impairment at 3–4 mo and improved memory by 7 mo. GSK356278 inhibited mf‐LTP deficits in a dose‐dependent manner. ISO also reduced hyperphosphorylation of synapsin I and microgliosis. DISCUSSION These findings suggest that β‐AR activation and phosphodiesterase 4 (PDE4) inhibition mitigate oAβ‐induced memory deficits, supporting enhanced cAMP signaling as a therapeutic target for early AD. Highlights Early episodic memory deficits in AD linked to oAβ‐induced synaptic dysfunction. Isoproterenol and GSK356278 improve mossy fiber‐LTP and fear memory deficits. FLIM‐FRET shows treatments restore cAMP signaling in dentate gyrus neurons. Isoproterenol reduces synapsin I hyperphosphorylation and microgliosis. Enhancing cAMP signaling may help mitigate early memory deficits in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ann Romney Center for Neurologic Diseases, Department of Neurology, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA.
- MicRoN Core, Harvard Medical School, Boston, Massachusetts, USA.
- Center for Nanoscale Systems, Harvard University, Cambridge, Massachusetts, USA.
- Mouse Behavior Core, Harvard Medical School, Boston, Massachusetts, USA.
Förderung
- NINDS NIH HHS
- NIH Blueprint for Neuroscience Research
- The Davis Alzheimer's Prevention Program
Zitieren
APA
Jin, S. X., Bellier, J. P., Wells, A., LIopis, P. M., Anekal, P. V., Tresback, J. S., Caldarone, B. J., Liu, L., Li, S., Dettmer, U., Ramalingam, N., & Selkoe, D. J. (2025). Inhibition of hippocampal mossy fiber plasticity and episodic memory by human Aβ oligomers is prevented by enhancing cAMP signaling in Alzheimer's mice. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70194
Vancouver
Jin SX, Bellier JP, Wells A, LIopis PM, Anekal PV, Tresback JS, et al. Inhibition of hippocampal mossy fiber plasticity and episodic memory by human Aβ oligomers is prevented by enhancing cAMP signaling in Alzheimer's mice. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70194
BibTeX
@article{Jin2025,
author = {Jin, Shan-Xue and Bellier, Jean-Pierre and Wells, Adrienne and LIopis, Paula Montero and Anekal, Praju Vikas and Tresback, Jason S and Caldarone, Barbara J and Liu, Lei and Li, Shaomin and Dettmer, Ulf and Ramalingam, Nagendran and Selkoe, Dennis J},
title = {Inhibition of hippocampal mossy fiber plasticity and episodic memory by human Aβ oligomers is prevented by enhancing cAMP signaling in Alzheimer's mice},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70194}
}
EUVIMED